Whitepaper

COVID-19
Know how Pharma industry is trying to free the whole world from the clutches of novel human coronavirus SARS-CoV-2
COVID-19 Whitepaper

More Whitepapers / Newsletters

Raynaud's Phenomenon Newsletter
Raynaud's Phenomenon

Raynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused by episodic vasospasm and ischemia of the extremities in response to cold or emotional stimuli. Usually...

Warm Autoimmune Hemolytic Anemia
Warm Autoimmune Hemolytic Anem...

Autoimmune hemolytic anemia (AIHA) is a rare acquired autoimmune disease. It is caused by the dysfunction in the immune system in which the immune system attacks its red blood cells considering them f...

Fragile X Syndrome Newsletter
Fragile X Syndrome

Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the physical characteristics of the people, and is a result of mutation associated with the gene FMR1. D...

Car-T Cell Therapy: A Journey From Challenges To Opportunities
Car-T Cell Therapy: A Journey...

With its innovative approach, chimeric antigen receptor T cell therapy created a new dawn in the age of cancer. Immunotherapy can be taken as a very powerful tool that can alter the immune system's pi...

Systemic Scleroderma Market
Systemic Scleroderma

Systemic scleroderma (SSC or systemic sclerosis) is an autoimmune disorder that results into scar tissues (fibrosis) on the skin and internal organs. The prevalence of systemic scleroderma is about 30...